BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1742 related articles for article (PubMed ID: 11174732)

  • 21. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
    Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves.
    Ruel M; Rubens FD; Masters RG; Pipe AL; Bédard P; Hendry PJ; Lam BK; Burwash IG; Goldstein WG; Brais MP; Keon WJ; Mesana TG
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):149-59. PubMed ID: 14752425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability?
    David TE; Armstrong S; Maganti M
    Ann Thorac Surg; 2010 Sep; 90(3):775-81. PubMed ID: 20732495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
    Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients.
    D'Onofrio A; Auriemma S; Magagna P; Favaro A; Cannarella A; Piccin C; Bilotta M; Abbiate N; Lamascese N; Fabbri A
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):491-5. PubMed ID: 17662795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of the Carpentier-Edwards SAV and Hancock-II porcine bioprostheses in aortic valve replacement.
    Jamieson WR; David TE; Feindel CM; Miyagishima RT; Germann E
    J Heart Valve Dis; 2002 May; 11(3):424-30. PubMed ID: 12056738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Hancock II porcine bioprosthesis. A preliminary report.
    Bortolotti U; Milano A; Mazzucco A; Guerra F; Magni A; Santini F; Gallucci V
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):415-20. PubMed ID: 2918737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twenty-five year experience with the St. Jude medical mechanical valve prosthesis.
    Toole JM; Stroud MR; Kratz JM; Crumbley AJ; Bradley SM; Crawford FA; Ikonomidis JS
    Ann Thorac Surg; 2010 May; 89(5):1402-9. PubMed ID: 20417752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of patient-prosthesis mismatch on long-term results after aortic valve replacement with a stented bioprosthesis.
    Frapier JM; Rouvière P; Razcka F; Aymard T; Albat B; Chaptal PA
    J Heart Valve Dis; 2002 Jul; 11(4):543-51. PubMed ID: 12150304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An eight-year experience with porcine bioprosthetic cardiac valves.
    Hartz RS; Fisher EB; Finkelmeier B; DeBoer A; Sanders JH; Moran JM; Michaelis LL
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):910-7. PubMed ID: 3713240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?
    Jamieson WR; Gudas VM; Burr LH; Janusz MT; Fradet GJ; Ling H; Germann E; Lichtenstein SV
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):104-10. PubMed ID: 19056294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary triple valve surgery for advanced rheumatic heart disease in Mainland China: a single-center experience with 871 clinical cases.
    Han QQ; Xu ZY; Zhang BR; Zou LJ; Hao JH; Huang SD
    Eur J Cardiothorac Surg; 2007 May; 31(5):845-50. PubMed ID: 17336080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aortic valve replacement with Toronto SPV bioprosthesis: optimal patient survival but suboptimal valve durability.
    David TE; Feindel CM; Bos J; Ivanov J; Armstrong S
    J Thorac Cardiovasc Surg; 2008 Jan; 135(1):19-24. PubMed ID: 18179912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twenty-year clinical experience with porcine bioprostheses.
    Fann JI; Miller DC; Moore KA; Mitchell RS; Oyer PE; Stinson EB; Robbins RC; Reitz BA; Shumway NE
    Ann Thorac Surg; 1996 Nov; 62(5):1301-11; discussion 1311-2. PubMed ID: 8893561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aortic valve replacement with mitral valve repair compared with combined aortic and mitral valve replacement.
    Talwar S; Mathur A; Choudhary SK; Singh R; Kumar AS
    Ann Thorac Surg; 2007 Oct; 84(4):1219-25. PubMed ID: 17888973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aortic valve replacement with the Sorin Pericarbon Freedom stentless valve: five-year follow up.
    Nyawo B; Graham R; Hunter S
    J Heart Valve Dis; 2007 Jan; 16(1):42-8. PubMed ID: 17315382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical results with the Ionescu-Shiley pericardial xenograft.
    Masters RG; Pipe AL; Bedard JP; Brais MP; Goldstein WG; Koshal A; Keon WJ
    J Thorac Cardiovasc Surg; 1991 Jan; 101(1):81-9. PubMed ID: 1986173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excellent durability of the Hancock porcine bioprosthesis in the tricuspid position. A sixteen-year follow-up study.
    Kawachi Y; Tominaga R; Hisahara M; Nakashima A; Yasui H; Tokunaga K
    J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1561-6. PubMed ID: 1453721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with stentless aortic xenografts.
    Luciani GB; Auriemma S; Casali G; Barozzi L; Lamascese N; Mazzucco A
    J Heart Valve Dis; 2000 Nov; 9(6):794-800. PubMed ID: 11128787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medtronic mosaic porcine bioprosthesis: investigational center experience to six years.
    Jamieson WR; Fradet GJ; MacNab JS; Burr LH; Stanford EA; Janusz MT; Abel JG; Germann E; Cheung A
    J Heart Valve Dis; 2005 Jan; 14(1):54-63. PubMed ID: 15700437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 88.